Evidence map›Paper›PMID 31703762›Full record

ReviewThe Journal of allergy and clinical immunology2019

Single-cell analysis to understand the diversity of immune cell types that drive disease pathogenesis.

Grégory Seumois, Pandurangan Vijayanand

Abstract readReview
In one paragraph

Review in The Journal of allergy and clinical immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Keratinocytes: pleiotropic orchestrators of cutaneous immunity and Inflammation - Emerging therapeutic paradigms in dermatological pathologies.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Insights into intestinal barrier disruption during long-term gutFrontiers in cellular and infection microbiology · 2025
    Article
  10. Review
  11. Review
  12. Cytotoxic CD4Med (New York, N.Y.) · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Single-cell transcriptomeFrontiers in cardiovascular medicine · 2022
    Article
  17. Epithelial barriers in allergy and asthma.The Journal of allergy and clinical immunology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Grégory SeumoisDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, Calif. Electronic address: gregory@lji.org.
Pandurangan VijayanandDivision of Vaccine Discovery, La Jolla Institute for Immunology, La Jolla, Calif.

Funding

Single-cell atlas of lung tissue-resident memory T cells reactive to upper and lower respiratory tract pathogensU19AI118626 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Pandurangan Vijayanand · 2015 to 2026
$36.7M
T follicular helper (Tfh) CD4+ T cell, germinal center, and antibody response dysfunction in human recurrent tonsillitisU19AI142742 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Shane P Crotty · 2019 to 2026
$32.8M
Epigenomics of T cells and innate immune cells in human asthmaR01HL114093 · NHLBI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI ARSHAD, SYED HASAN, PETERS, BJOERN · 2011 to 2020
$8.5M
Understanding mechanisms in specific immunotherapy (SIT)U19AI100275 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SETTE, ALESSANDRO · 2012 to 2017
$8.1M
Towards the identification of biomarkers for pediatric milk allergyU19AI135731 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI VIJAYANAND, PANDURANGAN · 2018 to 2022
$5.6M
Epigenome-wide association study of childhood asthmaR01AI121426 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI ARSHAD, SYED HASAN, PETERS, BJOERN · 2017 to 2021
$3.9M
NHLBI NIH HHS R01 HL114093NIAID NIH HHS R01 AI121426NIAID NIH HHS U19 AI100275NIAID NIH HHS U19 AI118626NIAID NIH HHS U19 AI135731NIAID NIH HHS U19 AI142742
6 · The paper itself

Abstract

Single-cell next-generation sequencing assays are powerful tools to understand the nature of the immune cells that drive disease pathogenesis. In this brief review we explain the value of performing assays at single-cell resolution to better understand the pathogenesis of allergy, asthma, and other lung diseases. We explain the challenges in performing single-cell studies of airways and lung samples from patients with lung diseases. A major limitation comes from the amount of diseased tissue that can be used for research purposes. Finally, we discuss which sequencing strategies can be used to successfully investigate airway and lung diseases at single-cell resolution.

Indexed as

AnimalsAsthmaHigh-Throughput Nucleotide SequencingHumansHypersensitivityImmunity, CellularLungLung DiseasesRespiratory SystemSingle-Cell Analysisairway diseaseSingle-cell RNA sequencingSmart-seq2

Identifiers

PMID31703762
PMCPMC7595676

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.